Sponsored Links
| Provectus Pharmaceuticals Completes Patient Accrual In Phase 2C Clinical Trial Of PH-10 For Psoriasis |
 |
 |
 |
| Medical News - Eczema and Psoriasis | |||
|
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has completed patient accrual in its Phase 2C clinical trial of PH-10 for the treatment of psoriasis... Read more: Eczema / Psoriasis News From Medical News Today
|